Phosphatidylserine — Research Profile

PS appears to modulate cortisol at the HPA axis level — specifically by reducing the sensitivity of the pituitary gland to corticotropin-releasing hormone (CRH), which blunts the downstream cortisol release from the adrenal glands. This does not suppress cortisol to unhealthy low levels; rather, it prevents excessive cortisol spikes during stress, essentially raising your stress threshold. This mechanism was demonstrated in the Monteleone (1992) exercise stress study.

Most clinical studies used soy-derived PS, so it has the strongest evidence base. However, sunflower-derived PS has an identical molecular structure and is expected to have equivalent effects. Choose sunflower PS if you have soy allergies or prefer to avoid soy. Both are dramatically safer than the original bovine cortex-derived PS, which was phased out due to prion disease concerns.

PS may help with sleep indirectly by reducing elevated evening cortisol levels. High cortisol at night is a common cause of difficulty falling asleep and light, fragmented sleep. By blunting the cortisol stress response, PS can help normalize the natural cortisol rhythm (high in morning, low at night), creating better conditions for sleep onset. It is particularly useful for people whose insomnia is driven by stress and overthinking.

Soy- and sunflower-derived phosphatidylserine are the standard plant forms, and soy PS has the most human trial support and is the form Health Canada assessed as safe. The bovine brain-cortex PS used in the earliest cortisol studies has been replaced by plant sources. PS conjugated with omega-3 is marketed but did not beat placebo for ADHD symptoms in a controlled trial, so it is not clearly superior.

The best-supported effect is blunting the cortisol and ACTH rise from exercise stress, shown at 600-800 mg/day over about 10 days (600 mg with moderate-intensity exercise, 800 mg with strenuous physical exertion). In older adults with mild cognitive impairment, soy PS at 100-300 mg/day for 6 months improved memory, particularly delayed verbal recall, and mainly in those with lower baseline scores. A meta-analysis also found a modest reduction in inattention in children with ADHD (effect size 0.36), though overall ADHD symptoms were not significantly changed.

Cognitive trials most often used 100-300 mg/day, and Health Canada supports intakes up to 300 mg/day. Pediatric ADHD studies used 200-300 mg/day, while exercise-cortisol studies used higher short-term doses of 600-800 mg/day. No single standardized dose is established across uses, but 300 mg/day is the common upper anchor for ongoing daily supplementation.

Timing has not been directly compared in trials, and phosphatidylserine can be taken with or without food. When used for stress- or sleep-related complaints, some guidance suggests a bedtime dose. Cortisol and cognition studies dosed it daily without establishing an optimal time of day.

Reported side effects are usually mild and gastrointestinal, such as upset stomach and gas, along with occasional insomnia, headache, or skin rash, and higher doses increase their likelihood. In controlled trials at up to 300 mg/day, no side effects were observed and blood markers and vital signs were unchanged.

Phosphatidylserine may reduce the effectiveness of anticholinergic medications such as atropine, scopolamine, and some antihistamines. Because PS may raise acetylcholine, it could also add to the effects of acetylcholinesterase inhibitors used for Alzheimer's disease, such as donepezil and rivastigmine, so those combinations warrant medical supervision. No interaction with anticoagulants is documented in the sources reviewed.

The most-studied groups are older adults with mild memory complaints, who showed memory gains over 6 to 12 months, and athletes or others seeking to blunt exercise- and stress-induced cortisol. Evidence in children with ADHD is limited and mixed, modest for inattention but negative for a PS-omega-3 formulation. People with a shellfish allergy should avoid marine-derived products, and safety in pregnancy and breastfeeding is not established.

The timeline depends on the outcome. Cortisol-blunting appears quickly, with a reduced exercise cortisol and ACTH response measured after just 10 days of 600-800 mg/day, and EEG markers of a more relaxed state emerging over about 6 weeks. Memory and cognitive benefits in older adults, by contrast, were assessed over much longer periods of 6 to 12 months of daily use.

The longest rigorous phosphatidylserine-only controlled trial ran 6 months, giving soy PS at 100-300 mg/day to older adults, and reported no side effects with blood markers and vital signs unchanged. An authoritative supplement monograph rates PS as possibly safe when taken orally for up to about six months, with side effects such as insomnia and stomach upset becoming more likely above 300 mg/day. Safety beyond roughly six months of continuous use, and at the 600-800 mg doses used briefly in cortisol studies, has not been well established.

There is no formal tolerable upper limit, but Health Canada set 300 mg/day (and 300 mg per serving) as the supported safe intake for soy PS. Short-term studies gave 600-800 mg/day for 10 days without reported harm, though these were brief and not designed to assess chronic high-dose safety. Exceeding recommended amounts raises the likelihood of side effects such as stomach upset, insomnia, and headache.

Phosphatidylserine is often co-formulated with omega-3 fatty acids, but a PS-omega-3 conjugate did not outperform placebo for ADHD symptoms in children, so combining does not guarantee added benefit. No adverse supplement-to-supplement interaction is documented in the sources reviewed. The more relevant caution is pharmacological rather than nutritional, since PS may reduce the effect of anticholinergic drugs and may add to the effect of acetylcholinesterase inhibitors, so it should be paired with medications only under clinician guidance.

Check the source. Most current products use soy- or sunflower-derived phosphatidylserine, and soy PS carries the strongest safety and efficacy record; the bovine brain-cortex material used in the earliest trials has largely been replaced by plant sources such as soy and cabbage. If you have a shellfish allergy, avoid marine-derived PS and choose a plant source. Look for a clinically studied per-serving dose in the 100-300 mg range.